Western University will be using a $5M donation to establish two endowed research chairs named in honor of donors Archie and Irene Verspeeten. The Verspeeten Chair in Translational Cancer Research will focus on accelerating cancer diagnosis and care using cutting-edge tools and approaches, while the Verspeeten Chair in Oncology will work to uncover mechanisms that drive cancer to ultimately improve patient outcomes. The funding—which has been matched by Western—was provided through London Health Sciences Foundation. Western Schulich Professor Dr Michael Ott has been named to the Verspeeten Chair in Oncology. “We envision this role as a catalyst for innovation, helping to develop new therapies and treatment pathways that can lead to patient clinical trials,” said Ott.